ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669727 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669727; 2) Community: the network communities that were significantly associated with the response to NSC 669727; 3) Molecule: the relationships between components within communities and NSC 669727; 4) MDR: the compounds that were significantly associated with the NSC 669727.

NSC Compound Enrichment Correlation
NSC 700361 Pyrazine-2,3-dicarbonitrile, 5,6-bis(5-methyl-1,3,4-thiadiazol-2-yl)- 0.00272369215216526 -0.041412543
NSC 726144 Waol A FD-211 0.00272369215216526 0.034127045
NSC 268993 Deferoxamine hydrochloride 0.0027236921521653 0.43928928
NSC 636679 Null 0.00356914129105574 0.02052473
NSC 681646 Camptothecin Derivative 0.00356914129105577 0.72527112
NSC 735373 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.00356914129105577 0.24621932
NSC 338947 Clomesone 0.00396536695012846 0.46264571
NSC 681644 Camptothecin Derivative 0.00396536695012846 0.70393828
NSC 698394 Piperidine, 1,1'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1Z,3E)- 0.00396536695012846 0.041138795
NSC 698398 1,3-Butadiene-1,1-diamine, 3,4-dichloro-2,4-dinitro-N,N'-diphenyl-, (3E)- 0.00396536695012846 0.0041207683
Total:43  Current:3    [First] [Prev] [Next] [Last]